Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Morphine Drip Administration Guidelines

Initial Assessment and Route Selection

  • Intravenous morphine is indicated for severe pain requiring rapid titration, particularly in patients unable to take oral medications or those with pain intensity NRS ≥5, as recommended by the European Society for Medical Oncology 1, 2
  • The IV route achieves peak effects within 15-30 minutes, making it superior to oral administration for rapid pain control, according to the American Society of Clinical Oncology 3

Starting Doses for IV Morphine

  • For severe cancer pain requiring rapid titration, a dose of 1.5 mg IV bolus every 10 minutes until pain relief or adverse effects occur is recommended by the European Society for Medical Oncology 1, 2
  • The median dose to achieve pain relief with this protocol is 4.5 mg (range 1.5-34.5 mg), as reported by the European Society for Medical Oncology 1, 2

Continuous Infusion Protocol

  • After initial bolus titration, convert to continuous infusion by calculating the total IV morphine required in the first 24 hours, as recommended by the European Society for Medical Oncology 1, 2
  • Provide breakthrough doses equal to 10-15% of the total daily dose, available every 15-30 minutes for IV administration, according to the European Society for Medical Oncology 1, 2

Titration and Dose Adjustment

  • Review total morphine consumption (basal infusion plus breakthrough doses) every 24 hours, as recommended by the National Comprehensive Cancer Network 6
  • If more than 4 breakthrough doses are needed per day, increase the baseline infusion rate, according to the European Society for Medical Oncology 1, 2

Dose Modifications

  • In renal impairment (eGFR <30 mL/min), start with lower doses and titrate slowly—morphine metabolites accumulate and cause toxicity, as recommended by the European Society for Medical Oncology 1, 2, 4

Concurrent Medications

  • Prescribe laxatives routinely for prophylaxis of opioid-induced constipation, as recommended by the European Society for Medical Oncology 4
  • Prescribe antiemetics (metoclopramide or antidopaminergics) for opioid-related nausea/vomiting, according to the European Society for Medical Oncology 4

Transition to Oral Therapy

  • Once pain is controlled on IV morphine, convert to oral immediate-release morphine every 4 hours using a 1:2 to 1:3 IV:oral ratio, as recommended by the European Society for Medical Oncology 2, 4